Trial site
Inje University Busan Paik Hospital
- 27running trials
- 17closed trials
The trials here
What the 44 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease9 trials
- Colorectal cancer3 trials
- Heart failure3 trials
- Idiopathic pulmonary fibrosis3 trials
- Multiple myeloma3 trials
- Cervical cancer2 trials
- Chronic kidney disease2 trials
- Diffuse large B-cell lymphoma2 trials
- Follicular lymphoma2 trials
- Myeloproliferative neoplasms2 trials
- Primary biliary cholangitis2 trials
- Stroke2 trials
- and 17 more
- Phase
- Phase 321 trials
- Phase 25 trials
- Phase 43 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Completed16 trials
- Recruiting14 trials
- Active, not recruiting11 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Boehringer Ingelheim5 trials
- Janssen Research & Development, LLC3 trials
- Regeneron Pharmaceuticals3 trials
- Seung-Jung Park3 trials
- Bayer2 trials
- and 26 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
Recruiting
Active, not recruiting
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Recruiting
Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr
Active, not recruiting
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Active, not recruiting
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
Active, not recruiting
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Recruiting
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Active, not recruiting
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
Active, not recruiting
Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)
Active, not recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease5 recruiting
- Heart failure2 recruiting
- Cervical cancer1 recruiting
- Chronic kidney disease1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- High blood pressure1 recruiting
- Huntington's disease1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver and biliary tract cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma
Completed
Early Feeding Versus Delayed Feeding After Colorectal Endoscopic Submucosal Dissection
Completed
A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder
Completed
A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Recruiting
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
Completed
Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026